miRò: a miRNA knowledge base.

MicroRNA profiling: approaches and considerations. Nat Rev Genet (2012) 4.39

miRandola: extracellular circulating microRNAs database. PLoS One (2012) 1.43

Identifying miRNAs, targets and functions. Brief Bioinform (2012) 1.35

Circulating miRNA biomarkers for Alzheimer's disease. PLoS One (2013) 1.22

CyTargetLinker: a cytoscape app to integrate regulatory interactions in network analysis. PLoS One (2013) 1.19

In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. J Exp Med (2013) 1.13

Bioinformatic tools for microRNA dissection. Nucleic Acids Res (2015) 1.02

miRNEST database: an integrative approach in microRNA search and annotation. Nucleic Acids Res (2011) 0.99

Genome-wide multi-omics profiling of colorectal cancer identifies immune determinants strongly associated with relapse. Front Genet (2013) 0.99

HuntMi: an efficient and taxon-specific approach in pre-miRNA identification. BMC Bioinformatics (2013) 0.96

Variability in the incidence of miRNAs and genes in fragile sites and the role of repeats and CpG islands in the distribution of genetic material. PLoS One (2010) 0.93

deepBase v2.0: identification, expression, evolution and function of small RNAs, LncRNAs and circular RNAs from deep-sequencing data. Nucleic Acids Res (2015) 0.91

miR-EdiTar: a database of predicted A-to-I edited miRNA target sites. Bioinformatics (2012) 0.89

Identification of differentially expressed microRNA in parathyroid tumors. Ann Surg Oncol (2010) 0.87

The potential of microRNAs in personalized medicine against cancers. Biomed Res Int (2014) 0.84

Comprehensive reconstruction and visualization of non-coding regulatory networks in human. Front Bioeng Biotechnol (2014) 0.84

Network analysis of microRNAs and their regulation in human ovarian cancer. BMC Syst Biol (2011) 0.81

ReNE: a cytoscape plugin for regulatory network enhancement. PLoS One (2014) 0.79

FARNA: knowledgebase of inferred functions of non-coding RNA transcripts. Nucleic Acids Res (2016) 0.78

miR-579-3p controls melanoma progression and resistance to target therapy. Proc Natl Acad Sci U S A (2016) 0.78

Analysis of Glioblastoma Patients' Plasma Revealed the Presence of MicroRNAs with a Prognostic Impact on Survival and Those of Viral Origin. PLoS One (2015) 0.78

MicroRNAs in melanoma development and resistance to target therapy. Oncotarget (2017) 0.78

'Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients'. Sci Rep (2016) 0.77

Circulating microRNA-320a and microRNA-486 predict thiazolidinedione response: Moving towards precision health for diabetes prevention. Metabolism (2015) 0.77

Circulating micrornas associated with glycemic impairment and progression in Asian Indians. Biomark Res (2015) 0.77

miRNAs and their putative roles in the development and progression of Parkinson's disease. Front Genet (2013) 0.77

Circulating microRNAs and Bioinformatics Tools to Discover Novel Diagnostic Biomarkers of Pediatric Diseases. Genes (Basel) (2017) 0.77

Effectiveness and Usability of Bioinformatics Tools to Analyze Pathways Associated with miRNA Expression. Cancer Inform (2015) 0.76

Intestinal and Circulating MicroRNAs in Coeliac Disease. Int J Mol Sci (2017) 0.75

Web-based tools for microRNAs involved in human cancer. Oncol Lett (2016) 0.75

Urinary microRNAs as potential biomarkers of pesticide exposure. Toxicol Appl Pharmacol (2016) 0.75

Simultaneous Detection of Different MicroRNA Types Using the ZIP-Code Array System. J Nucleic Acids (2013) 0.75

MIRNA-DISTILLER: A Stand-Alone Application to Compile microRNA Data from Databases. Front Genet (2011) 0.75

ProteoMirExpress: inferring microRNA and protein-centered regulatory networks from high-throughput proteomic and mRNA expression data. Mol Cell Proteomics (2013) 0.75

Targeting BTK through microRNA in chronic lymphocytic leukemia. Blood (2016) 0.75

Large-scale prediction of microRNA-disease associations by combinatorial prioritization algorithm. Sci Rep (2017) 0.75

Improving biocuration of microRNAs in diseases: a case study in idiopathic pulmonary fibrosis. Database (Oxford) (2017) 0.75

Enhanced Expression of FRA16B using AT-Rich DNA Binding Chemicals in a Woman with Secondary Amenorrhoea. J Clin Diagn Res (2017) 0.75

Increased complexin-1 and decreased miR-185 expression levels in Behçet's disease with and without neurological involvement. Neurol Sci (2015) 0.75

Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52

MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell (2005) 96.87

The functions of animal microRNAs. Nature (2004) 64.85

Combinatorial microRNA target predictions. Nat Genet (2005) 50.48

miRBase: tools for microRNA genomics. Nucleic Acids Res (2007) 38.61

A mammalian microRNA expression atlas based on small RNA library sequencing. Cell (2007) 34.03

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med (2005) 26.02

miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A (2005) 21.51

Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell (2008) 12.29

The genetic association database. Nat Genet (2004) 11.29

A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res (2005) 10.46

miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res (2008) 8.97

miRiad roles for the miR-17-92 cluster in development and disease. Cell (2008) 8.02

Myogenic factors that regulate expression of muscle-specific microRNAs. Proc Natl Acad Sci U S A (2006) 6.19

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med (2008) 5.91

Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A (2008) 5.24

miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem (2007) 5.02

The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci (2008) 4.28

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Hum Genet (2008) 3.27

MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci U S A (2007) 3.00

Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J Biol Chem (2008) 2.72

miRGator: an integrated system for functional annotation of microRNAs. Nucleic Acids Res (2007) 2.59

Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J (2008) 2.58

Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol Clin Exp Res (2007) 1.97

Genetics. Erasing microRNAs reveals their powerful punch. Science (2007) 0.84

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46

First report of post-weaning multisystemic wasting syndrome in pigs in Spain. Vet Rec (1997) 3.45

A sore eye and meningitis. Lancet (1995) 2.34

NetMatch: a Cytoscape plugin for searching biological networks. Bioinformatics (2007) 1.96

National seasonal influenza vaccination survey in Europe, 2008. Euro Surveill (2008) 1.63

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies. Diagn Pathol (2011) 1.57

Nutritional state and exercise tolerance in patients with COPD. Chest (1995) 1.52

Oral surgery: Mandibular fracture risk. Br Dent J (2016) 1.40

[Hemodynamic and coronary angiographic performance at a center with medium-low activity: organization model, activity indicators, and costs]. Ital Heart J Suppl (2000) 1.39

Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. Oncogene (2012) 1.35

Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation. Hepatology (2000) 1.32

Functional identification of rat atypical beta-adrenoceptors by the first beta 3-selective antagonists, aryloxypropanolaminotetralins. Br J Pharmacol (1996) 1.32

HLA-B27 antigen in diagnosis of atypical seronegative inflammatory arthropathy. Ann Rheum Dis (1976) 1.32

Trinucleotide repeats in 202 families with ataxia: a small expanded (CAG)n allele at the SCA17 locus. Arch Neurol (2002) 1.26

Discovering active motifs in sets of related protein sequences and using them for classification. Nucleic Acids Res (1994) 1.24

Clinical pharmacology: a declaration of intent. Br J Clin Pharmacol (2010) 1.18

Cellular and molecular effects of protons: apoptosis induction and potential implications for cancer therapy. Apoptosis (2006) 1.18

Pattern and management of recurrent hepatocellular carcinoma after liver transplantation. J Hepatobiliary Pancreat Surg (1998) 1.17

Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12

An unusual tonsillolithiasis in a patient with chronic obstructive sialoadenitis. Dentomaxillofac Radiol (2005) 1.12

Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11

In vivo genetic variability of the human immunodeficiency virus type 2 V3 region. J Virol (1992) 1.11

Methylation-dependent silencing of the testis-specific Pdha-2 basal promoter occurs through selective targeting of an activating transcription factor/cAMP-responsive element-binding site. J Biol Chem (2000) 1.10

Improvement in the molecular diagnosis of Machado-Joseph disease. Arch Neurol (2001) 1.07

UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas. Oncogene (2006) 1.06

S-Nitrosothiols: a class of nitric oxide-donor drugs. Clin Sci (Lond) (2000) 1.06

Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76  TeV. Phys Rev Lett (2011) 1.05

Ventilatory and metabolic adaptations to walking and cycling in patients with COPD. J Appl Physiol (1985) (2000) 1.04

Distribution of hepatitis B virus genotypes in two different pediatric populations from Argentina. J Clin Microbiol (1998) 1.03

The l2 minor capsid protein of low-risk human papillomavirus type 11 interacts with host nuclear import receptors and viral DNA. J Virol (2006) 1.03

Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle. J Cardiovasc Pharmacol (1993) 1.01

Neurologic findings in Machado-Joseph disease: relation with disease duration, subtypes, and (CAG)n. Arch Neurol (2001) 1.00

Regulation of glucose homeostasis in humans with denervated livers. J Clin Invest (1997) 0.98

Production of muons from heavy flavor decays at forward rapidity in pp and Pb-Pb collisions at sqrt[s(NN)]=2.76  TeV. Phys Rev Lett (2012) 0.98

Low coverage of seasonal influenza vaccination in the elderly in many European countries. Euro Surveill (2008) 0.98

Vascular malformations of the tongue: MRI findings on three cases. Dentomaxillofac Radiol (2006) 0.97

Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study. BJOG (2013) 0.97

S-nitrosothiols as nitric oxide-donors: chemistry, biology and possible future therapeutic applications. Curr Med Chem (2004) 0.97

The American Brachytherapy Society recommendations for brachytherapy of soft tissue sarcomas. Int J Radiat Oncol Biol Phys (2001) 0.97

Resection versus transplantation for liver metastases from neuroendocrine tumors. Transplant Proc (2001) 0.96

Increased platelet aggregation in vivo in the Zucker Diabetic Fatty rat: differences from the streptozotocin diabetic rat. Br J Pharmacol (2006) 0.96

Characteristics of patients with allergic polysensitization: the POLISMAIL study. Eur Ann Allergy Clin Immunol (2008) 0.95

Saccharomyces uvarum, a distinct group within Saccharomyces sensu stricto. FEMS Microbiol Lett (1999) 0.95

beta(2)-adrenoceptors activate nitric oxide synthase in human platelets. Circ Res (2000) 0.94

Karyotyping of Saccharomyces strains with different temperature profiles. J Appl Microbiol (1998) 0.94

On the use of antibiotics to reduce rhizoplane microbial populations in root physiology and ecology investigations. Physiol Plant (1995) 0.93

Population genetics of wild-type CAG repeats in the Machado-Joseph disease gene in Portugal. Hum Hered (2005) 0.93

Centrality dependence of the charged-particle multiplicity density at midrapidity in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2011) 0.93

Telomere length maintenance in aging and carcinogenesis. Int J Oncol (2000) 0.92

Nitric oxide-dependent vasodilatation of rabbit femoral artery by beta(2)-adrenergic stimulation or cyclic AMP elevation in vivo. Br J Pharmacol (2000) 0.92

Beta-adrenergic receptors and nitric oxide generation in the cardiovascular system. Cell Mol Life Sci (2006) 0.91

Prevalence of anemia in cancer patients undergoing radiation therapy. Semin Oncol (2001) 0.90

Candida humilis--dominant species in sourdoughs for the production of durum wheat bran flour bread. Int J Food Microbiol (2003) 0.89

Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment. Transplant Proc (2001) 0.89

Beta adrenoreceptor subtype cross regulation in the human heart. Br Heart J (1993) 0.89

Acute disseminated encephalomyelitis: a long-term prospective study and meta-analysis. Neuropediatrics (2011) 0.88

Increased salience of gains versus decreased associative learning differentiate bipolar disorder from schizophrenia during incentive decision making. Psychol Med (2012) 0.88

Changes in cerebrospinal fluid magnesium levels in patients undergoing spinal anaesthesia for hip arthroplasty: does intravenous infusion of magnesium sulphate make any difference? A prospective, randomized, controlled study. Br J Anaesth (2012) 0.88

Immunohistochemical telomeric-repeat binding factor-1 expression in gastrointestinal tumors. Oncol Rep (2000) 0.88

SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo. Eur J Pharmacol (1993) 0.87

Midrapidity antiproton-to-proton ratio in pp collisons at sqrt[s]=0.9 and 7 TeV measured by the ALICE experiment. Phys Rev Lett (2010) 0.87

N-Acetylcysteine counteracts erythrocyte alterations occurring in chronic obstructive pulmonary disease. Biochem Biophys Res Commun (2000) 0.87

Liver transplantation for small hepatocellular carcinoma in cirrhosis: analysis of our experience. Transplant Proc (2001) 0.86

[Genotype characterization of hepatitis C virus infection in children]. Medicina (B Aires) (2001) 0.86

Effect of reduced body weight on muscle aerobic capacity in patients with COPD. Chest (1998) 0.85

Development and daily use of an electronic oncological patient record for the total management of cancer patients: 7 years' experience. Ann Oncol (2008) 0.85

A survey of spinocerebellar ataxia in South Brazil - 66 new cases with Machado-Joseph disease, SCA7, SCA8, or unidentified disease-causing mutations. J Neurol (2001) 0.85

Levallorphan methyl iodide (SR 58002), a potent narcotic antagonist with peripheral selectivity superior to that of other quaternary compounds. Life Sci (1983) 0.85

Genomic and phylogenetic analysis of hepatitis C virus strains from Argentina. Medicina (B Aires) (1998) 0.85

Metabolic effects of liver transplantation in cirrhotic patients. J Clin Invest (1997) 0.85

Evaluation of polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral cells by an immunohistochemical assay. Cancer Epidemiol Biomarkers Prev (1999) 0.85

Rapid differentiation of the closely related Kluyveromyces lactis var. lactis and K. marxianus strains isolated from dairy products using selective media and PCR/RFLP of the rDNA non transcribed spacer 2. Can J Microbiol (2000) 0.84

Universal varicella vaccination in the Veneto Region, Italy: launch of a programme targeting all children aged 14 months and susceptible adolescents. Euro Surveill (2007) 0.84

Comparison of the vasoconstrictor properties of the 5-HT1D-receptor agonists rizatriptan (MK-462) and sumatriptan in human isolated coronary artery: outcome of two independent studies using different experimental protocols. Funct Neurol (1997) 0.84

Electrophoretic profile of hybrids between cryotolerant and non-cryotolerant Saccharomyces strains. Lett Appl Microbiol (1998) 0.84

The "Green Channel" of the Veneto region as a model for vaccine safety monitoring in Italy. Vaccine (2005) 0.83

Conjunctival fibroblasts enhance the survival and functional activity of peripheral blood eosinophils in vitro. Invest Ophthalmol Vis Sci (2000) 0.83

Drug treatment of essential hypertension: the case for initial combination therapy. Int J Clin Pract (2004) 0.83

Correlation between Helicobacter pylori infection and IL-18 mRNA expression in human gastric biopsy specimens. Ann N Y Acad Sci (2002) 0.83

Atypical leishmaniasis in an HIV-2-seropositive patient from Guinea-Bissau. AIDS (1991) 0.83

Current status and future possibilities of nitric oxide-donor drugs: focus on S-nitrosothiols. Mini Rev Med Chem (2005) 0.82

Permanence of skeletal changes after function regulator (FR-2) treatment of patients with retrusive Class II malocclusions. Am J Orthod Dentofacial Orthop (1996) 0.82

[Hemangiopericytoma of the greater omentum. Videolaparoscopic treatment: case report and review of the literature]. Suppl Tumori (2006) 0.82

Characterization of T-lymphocyte subsets in hairy-cell leukaemia (HCL) by monoclonal antibodies: comparison with Fc gamma, Fc mu receptors and correlation with disease activity. Br J Haematol (1982) 0.82

[Biochemical profile of mycobacteria isolated from clinical and environmental material]. Quad Sclavo Diagn (1985) 0.82

Thermoluminescent dosimetry of the Symmetra 125I model I25.S06 interstitial brachytherapy seed. Med Phys (2001) 0.81

[Indications for percutaneous atrioseptostomy. Comparison of echocardiographic and fluoroscopic monitoring]. Pediatr Med Chir (1998) 0.81

Pulmonary masses in a patient with blue-gray cutaneous hyperpigmentation. Eur Rev Med Pharmacol Sci (2008) 0.81

Linguistic production and syntactic comprehension in schizophrenia and bipolar disorder. Acta Psychiatr Scand (2012) 0.81

In vivo study of polyurethane-coated Gianturco-Rosch biliary Z-stents. Cardiovasc Intervent Radiol (2000) 0.80

[Lymphedema of the upper extremity in patients operated for carcinoma of the breast: clinical experience with coumarinic extract from Melilotus officinalis]. Clin Ter (2000) 0.80

Pion, kaon, and proton production in central Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 0.80

Charge separation relative to the reaction plane in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2013) 0.80

J/ψ polarization in pp collisions at √s=7 TeV. Phys Rev Lett (2012) 0.80